Glancy Binkow & Goldberg LLP filed a shareholder class action lawsuit on
August 13, 2014, in the United States District Court for the Northern
District of California on behalf of purchasers of the securities of Impax
Laboratories, Inc. (“Impax” or the “Company”) (NASDAQ:IPXL).
The complaint alleges that throughout the Class Period, defendants made
materially false and misleading statements and/or failed to disclose
that: (1) Impax failed to maintain proper quality control and
manufacturing practices at its Taiwan facility, in violation of current
Good Manufacturing Practices; (2) the manufacturing deficiencies at the
Taiwan facility could have a material adverse impact on Impax’s ability
to successfully launch its new drug, RYTARY, a long-acting capsule to
treat the symptoms of Parkinson’s disease; and (3) these deficiencies
jeopardized Impax’s ability to manufacture,
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against EveryWare Global, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 8, 2014 -- EVRY investment picks
Mountain Valley Pipeline, LLC, a joint venture between affiliates of EQT
Corporation (NYSE: EQT) and NextEra Energy, Inc. (NYSE: NEE), today
announced that through its current open season it has secured 2 Bcf per
day of firm capacity commitments at 20-year terms for the Mountain
Valley Pipeline project.
(NYSE: CVT), a leading cloud-based enterprise event management platform,
today announced that it has launched a Supplier
Professional Certification program for hotel sales and marketing
professionals to demonstrate their knowledge of the Cvent
Supplier Network .
Sign-up for INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Durata Therapeutics Inc. Regarding the Fairness of the Sale of the Company to Actavis - ACT investment picks
Yum Brands Inc. (YUM) , the parent of Kentucky Fried Chicken and Pizza Hut, said Tuesday that its third-quarter profit rose to $404 million, or 89 cents a share, from $152 million, or 33 cents, a year earlier.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.